Effects of ionic and non-ionic contrast media on platelet function as evaluated by plasma concentration of beta-thromboglobulin

British Journal of Radiology

Volumn 70, Issue DEC., 1997, Pages 1239-1244

  Brzosko, M ^a   Cyrylowski L ^a   Brzosko, I ^a   Domanski Z ^a   Fiedorowicz Fabrycy, I ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; DIATRIZOATE; IONIC CONTRAST MEDIUM; IOPROMIDE; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ANGIOGRAPHY; ARTERIOGRAPHY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; THROMBOCYTE FUNCTION;

EID: 2642707551     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.70.840.9505842     Document Type: Article

References (34)

1. Beyer-Enke SA, Zeitler E. Late adverse reactions to non-ionic contrast media: a cohort analytic study. Eur Radiol 1993;3:237-41.
2. Del Favero C, Rossini G, Martegani A. A comparison of iopamidol and ioxaglate in CT enhancement. Eur Radiol 1993;1:77-82.
3. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990;175:621-8.
4. Thomsen HS, Dorph S. High-osmolar and low-osmolar contrast media (An update on frequency of adverse drug reactions). Acta Radiol 1993;34:205-9.
5. Palmer FJ. The Royal Australasian College of Radiologists (RACR) survey of reactions to intravenous ionic and non-ionic contrast media. In: Enge I, editor. Patients' safety and adverse events in contrast medium examinations. Oxford: Excerpta Medica, 1989:137-41.
6. Steinberg EP, Moore RD, Powe NR, et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 1992;326:425-30.
7. Barret BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992;326:431-6.
8. Brismar J, Jacobsson BF, Jorulf H. Miscellaneous adverse effects of low-versus high-osmolality contrast media: A study revised. Radiology 1991;179:19-23.
9. Hollas S. Previous reactors - values of premedication. In: Enge I, editor. Patients safety and adverse events in contrast medium examinations. Oxford: Excerpta Medica, 1989:97-100.
10. Ansell G. Adverse reactions to contrast agents. Scope of problems. Invest Radiol 1970;5:374-84.
11. Speck U. Kontrastmittel. Übersicht, Anwendung und pharmazeutische Aspecte. [Contrast media. Review, application and pharmacological aspect.] Berlin: Springer-Verlag, 1991:66-79.
12. Davidson CJ, Mark DB, Pieper KS, et al. Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: Analysis of 8,517 patients. Am J Cardiol 1990;65:1481-4.
13. Parvez Z, Moncada R, Gragasin M. Effects of ionic and non-ionic contrast agents on hemostatic pathways. In: Parvez Z, editor. Contrast media: biologic effect and clinical applications. Vol. I. Boca Raton, Florida: CRC Press, 1987:99-119.
14. Gafter U, Creter D, Zevin D, Catz R, Djaldetti M. Inhibition of platelet aggregation by contrast media. Radiology 1979;132:341-2.
15. Dawson P, Hewitt P, Mackie IJ, Machin SJ, Amin S, Bradshaw A. Contrast, coagulation, and fibrynolysis. Invest Radiol 1986;21:248-52.
16. Cella G, Zahavi J, De Haas A, Kakkar VV. β-Thromboglobulin, platelet production time and platelet function in vascular disease. Br J Haematol 1979;43:127-36.
17. Eloy R, Paul J, Freyria AM, Belleville J. Contrast media modification on platelet behavior. In: Parvez Z, editor. Contrast media: biologic effects and clinical applications. Vol. I. Boca Raton, Florida: CRC Press, 1987:121-50.
18. Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP. Elevated beta thromboglobulin in peripherial venous blood of patients with acute myocardial ischemia: Direct evidence for enhanced platelet reaction in vivo. Am J Cardiol 1981;48:395-402.
19. Dawes J, Smith RC, Pepper DS. The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4. Thromb Res 1978;5:851-61.
20. Polanowska R, Wilczynska M, Slawinska W, Goch JH, Augustyniak W, Cierniewski CS. Changes in platelet activity and tissue plasminogen activator during arteriography in patients with chronic limb ischaemia. Thromb Res 1992;65:663-5.
21. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation as important side effect of some types of contrast media used in interventional cardiology. Circulation 1993;88:2035-44.
22. Arora R, Khandelwal M, Gopal A. In vivo effects of nonionic and ionic contrast media on beta-thromboglobulin and fibrinopeptide levels. J Am Coll Cardiol 1991;17:1533-6.
23. Hwang MH, Piao ZE, Murdock DK, Messmore HL, Giardina JJ, Scanlon PJ. Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media. Radiology 1990;174:453-7.
24. Kopko PM, Smith DC, Bull BS. Thrombin generation in non-clottable mixtures of blood and nonionic contrast media. Radiology 1990;174:459-61.
25. Fareed J, Walenga JM, Saravia GE, Moncada RM. Thrombogenic potential of nonionic contrast media? Radiology 1990;174:321-5.
26. Stormorken H. Biocompatibility of contrast media as evaluated by their effects on the thrombotic and haemostatic mechanisms. In: Enge I, editor. Patients' safety and adverse events in contrast medium examinations. Oxford: Excerpta Medica, 1989:73-7.
27. Cyryłowski L, Brzosko I, Brzosko M. Wpływ jonowych środków cieniujacych na czynność płytek krwi oceniany na podstawie zachowania sie poziomu β-tromboglobuliny w osoczu krwi [Effects of ionic contrast media on platelet function as evaluated by the measurements of the plasma concentration of β-Thromboglobulin (abstract in English)]. Pol Przegl Radiol 1995;1:10-12.
28. Carr ME Jr, Carr SE, Merten SR. Effects of ionic and non-ionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots. Haemostasis 1995;25:172-81.
29. Wolff F, Zupan M, Klero de Rosbo P, Wiesel ML, Grunebaum L, Cazenave JP, et al. Risque thrombotique comparatif de deux agents de contraste en coronarographie [Comparative thrombotic risk of two contrast agents in coronary angiography]. Ann Radiol Paris 1994;37:435-9.
30. Holtas S, Almén T, Hellsten S, Tejler L. Proteinuria following nephroangiography. VI. Comparison between metrizoate and metrizamide in man. Acta Radiol (Diagn) 1980;21:491-4.
31. Almén T, Golman K. Contrast media pharmacokinetics in the assessment of renal failure. In: Parvez Z, editor. Contrast media: biologic effects and clinical applications. Vol. I. Boca Raton, Florida: CRC Press, 1987:77-95.
32. Dawson P, Laffan M. Platelet degranulation by intravascular contrast agents. Eur Radiol 1997;Suppl:S16.
33. Albanese JR, Venditto JA, Patel GC, Ambrose JA. Effects of ionic and nonionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 1995;76:1059-63.
34. Hay KL, Bull BS. An analysis of platelet activation and aggregation produced by three classes of contrast media. J Vasc Interv Radiol 1995;6:211-7.